StartupsINVESTApproved
Peptris Technologies secured an ₹86 crore grant from India’s RDI Fund
Bengaluru, Karnataka1 Oct 2026
Peptris Technologies, an AI-driven drug discovery startup incubated at C-CAMP in Bengaluru, secured ₹86 crore under the government’s Research, Development and Innovation (RDI) Fund earlier in October 2026. The company said it plans to use the grant to advance four assets through preclinical development as part of its rare-disease-focused pipeline.
Why it matters
Grant funding can enable Peptris to move multiple drug candidates further along preclinical development, increasing the chances of generating viable therapies for rare diseases with limited treatment options.
Peptris TechnologiesResearch, Development and Innovation (RDI) Fund